Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis

Background Although enzyme replacement therapy (ERT) is an effective treatment for mucopolysaccharidosis (MPS) types I, II, IVA and VI, its effectiveness in children with central nervous system (CNS) disorders is said to be poor because the blood–brain barrier cannot be penetrated by ERT drugs.